U.S. Markets closed

A Diabetes Treatment Revolution Could Bolster These Medtech Firms

ALLISON GATLIN
A Diabetes Treatment Revolution Could Bolster These Medtech Firms

Medical device companies like Abbott, Medtronic and Tandem Diabetes are jockeying for a piece of the diabetes treatment market, which could be worth north of $2 trillion by 2030.